跳至主要内容
临床试验/ITMCTR1900002527
ITMCTR1900002527招募中未知

A multicenter, randomized controlled clinical trial of Bi-Sai-Tong solution for moderate to severe allergic rhinitis

Guangdong Provincial Hospital of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 65(—)
性别
All

入选标准

  • 1. Aged 18 to 65 years, both men and women;
  • 2. Accorded with allergic rhinitis diagnostic criteria;
  • 3. moderate-severe allergic rhinitis;
  • 4. RQLQ scores >= 42 points
  • 5. Patients signed informed consent.

排除标准

  • 1. Patients with moderate-severe deviation of nasal septum, sinusitis, rhinopolyp, nasopharynx cancer and other severe nasal diseases;
  • 2. Patients with serious heart,liver,lung,kidney and blood system diseases;
  • 3. Patients with unstable asthma control;
  • 4. Psychiatric patients;
  • 5. Those who are in on-going trial or ready to attend other clinical trials;
  • 6. Allergic to the traditional Chinese medicine ingredients contained in the treatment drug;
  • 7. Women during pregnant stage and breast-feed stage.

研究者

发起方
Guangdong Provincial Hospital of Chinese Medicine

相似试验